BioSpace News Archive

Loan reinforces the financial foundation of the company and extends Sensorion cash runway until early Q4 2022

Confo Therapeutics announced the selection of its first preclinical drug candidate, CFTX-1554, a compound designed to address peripheral neuropathic pain with the potential to address additional pain indications.

BioInvent International AB and Transgene announce that they will be presenting a poster on BT-001 at the Society for Immunotherapy of Cancer 35th Anniversary Annual Meeting.

VectivBio’s investor syndicate expands to include Surveyor Capital (a Citadel company), Cormorant Capital and Eventide Asset Management

Bio-Techne Corporation, a leading provider of proteins, antibodies and cytokines announced that its Woburn, Massachusetts site received ISO 13485:2016 certification for Medical Device and Quality Management Systems.

Bausch Health Companies Inc. and Bausch + Lomb, its leading global eye health business, along with BHVI, an Australian not-for-profit organization with an international focus on vision research, announced that an affiliate of Bausch Health has acquired an exclusive license for a myopia control contact lens design developed by BHVI.

Harnessing the human skin microbiome to develop cutting-edge solutions moving the paradigm from treatment to cure in dermatology

Cytokines 2020 and SITC presentations to showcase Sec61 inhibition as a novel mechanism for blocking expression of therapeutically relevant targets such as cytokines and immune checkpoints

Walgreens Boots Alliance, Inc. announced financial results for the fiscal year and fourth quarter that ended August 31, 2020.

ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its third quarter 2020 earnings release and conference call.